GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for nicotinate phosphoribosyltransferase (B0RVE9)

Analyse AlphaFold monomer V2.0 prediction for nicotinate phosphoribosyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B0RVE9
Type
protein
Length
398 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x74fa9b3471789AeF6382E089eCD80c4a16336589
Molecule
Nicotinate phosphoribosyltransferase
UniProt
B0RVE9
Pockets
3 · best druggability 0.76

Structure

1 distinct chain · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinate phosphoribosyltransferaseprotein39849% helix, 15% strandB0RVE9

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13750.760.8645empty
21690.500.7724empty
31710.450.7526empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.